The latest study found for the first time that NMUR2 activation promoted signaling in colorectal cancer (CRC) cells, and that NMU improves the mobility and invasiveness of NMUR2-positive CRC cells (51). The gene discussed is NMUR2; the disease is colorectal cancer.